Details for Patent: 8,470,367
✉ Email this page to a colleague
Which drugs does patent 8,470,367 protect, and when does it expire?
Patent 8,470,367 protects ELEPSIA XR and is included in one NDA.
This patent has twenty-two patent family members in eighteen countries.
Summary for Patent: 8,470,367
| Title: | Oral drug delivery system |
| Abstract: | An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a composition selected from a swellable composition and a reactive composition located in an immediate vicinity of one or more preselected surfaces. The coating comprising water insoluble polymer(s) and leachable component(s) is operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces. |
| Inventor(s): | Bhalachandra Dharmadhikari; Nitin (Mumbai, IN), Rupsinh Zala; Yashoraj (Mumbai, IN), Singh; Amarjit (Mumbai, IN) |
| Assignee: | Sun Pharma Advanced Research Company Ltd. (Andheri (E), Mumbai, unknown) |
| Application Number: | 11/946,575 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Compound; |
Drugs Protected by US Patent 8,470,367
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tripoint | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-001 | Dec 20, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Tripoint | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-002 | Dec 20, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,470,367
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| India | 987/MUM/2003 | Sep 19, 2003 |
International Family Members for US Patent 8,470,367
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 200603602 | ⤷ Sign Up | |||
| Austria | 551051 | ⤷ Sign Up | |||
| Australia | 2004283565 | ⤷ Sign Up | |||
| Australia | 2011200881 | ⤷ Sign Up | |||
| Brazil | PI0414305 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
